Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis
Clicks: 196
ID: 273153
2013
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
HCV treatment outcomes are acceptable in PWID, supporting treatment guidelines. The pooled estimate of HCV reinfection risk was low, but there was considerable uncertainty around this estimate. Further studies on the risk of reinfection are needed to assess the long-term effectiveness of HCV treatme ā¦| Reference Key |
ej2013clinicaltreatment
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Aspinall EJ;Corson S;Doyle JS;Grebely J;Hutchinson SJ;Dore GJ;Goldberg DJ;Hellard ME;; |
| Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| Year | 2013 |
| DOI | DOI not found |
| URL | |
| Keywords |
systematic review
meta-analysis
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
non-u.s. gov't
Recurrence
substance abuse
viral load
intravenous / complications*
hepatitis c / drug therapy*
Medication Adherence
pmid:23884071
doi:10.1093/cid/cit306
esther j aspinall
stephen corson
margaret e hellard
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.